Michael E.  Paolucci net worth and biography

Michael Paolucci Biography and Net Worth

Director of Orthofix Medical
Mr. Paolucci was named to the Board of Directors and appointed to the Compensation Committee in March 2016. A seasoned Human Resource (HR) executive, he has more than 20 years of global experience working directly with Boards of Directors and C-level executives to improve organizational capabilities and HR programs that result in sustained improvements in business performance. Mr. Paolucci currently serves as the Executive Vice President, Human Capital at Arena Pharmaceuticals, a clinical stage biotechnology pharmaceutical company. From 2015 until 2020, he served as Vice President and Chief Human Resources Officer for Halozyme Therapeutics Inc. Prior to Halozyme, Mr. Paolucci served as Executive Vice President and Chief Human Resource Officer for CareFusion. Mr. Paolucci also served as Executive Vice President of Human Resources at NuVasive, and spent five years at Life Technologies. Previously, he was head of Human Resources for the services division of Hewlett Packard and served in several leadership roles with EDS, which was acquired by Hewlett Packard. Prior to HP/EDS, Mr. Paolucci was a partner with the HR consulting firm Towers Perrin. Mr. Paolucci is a graduate of Ohio State University.

How do I contact Michael E. Paolucci?

The corporate mailing address for Mr. Paolucci and other Orthofix Medical executives is 3451 Plano Parkway, Lewisville TX, 75056. Orthofix Medical can also be reached via phone at (214) 937-2000 and via email at [email protected]. Learn More on Michael E. Paolucci's contact information.

Has Michael E. Paolucci been buying or selling shares of Orthofix Medical?

Michael E. Paolucci has not been actively trading shares of Orthofix Medical during the past quarter. Most recently, on Monday, November 22nd, Michael E. Paolucci bought 2,000 shares of Orthofix Medical stock. The stock was acquired at an average cost of $31.15 per share, with a total value of $62,300.00. Learn More on Michael E. Paolucci's trading history.

Who are Orthofix Medical's active insiders?

Orthofix Medical's insider roster includes Catherine Burzik (Director), Rice Doug (CFO), Kimberley Elting (Insider), Michael Paolucci (Director), and Jon Serbousek (CEO). Learn More on Orthofix Medical's active insiders.

Are insiders buying or selling shares of Orthofix Medical?

In the last year, Orthofix Medical insiders bought shares 1 times. They purchased a total of 7,500 shares worth more than $101,025.00. In the last year, insiders at the medical device company sold shares 2 times. They sold a total of 8,243 shares worth more than $156,617.00. The most recent insider tranaction occured on September, 14th when Director James F Hinrichs bought 7,500 shares worth more than $101,025.00. Insiders at Orthofix Medical own 4.7% of the company. Learn More about insider trades at Orthofix Medical.

Information on this page was last updated on 9/14/2023.

Michael E. Paolucci Insider Trading History at Orthofix Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2021Buy2,000$31.15$62,300.00View SEC Filing Icon  
See Full Table

Michael E. Paolucci Buying and Selling Activity at Orthofix Medical

This chart shows Michael E Paolucci's buying and selling at Orthofix Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Orthofix Medical Company Overview

Orthofix Medical logo
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Read More

Today's Range

Now: $14.29
Low: $13.73
High: $14.29

50 Day Range

MA: $13.88
Low: $13.00
High: $14.62

2 Week Range

Now: $14.29
Low: $9.57
High: $21.60

Volume

211,391 shs

Average Volume

405,054 shs

Market Capitalization

$534.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03